-
My Account
In App
My Account
BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Nov 07, 10:48Prev. Close
1740.05
Open Price
1725.00
Bid Price (Qty.)
1661.30 (105)
Offer Price (Qty.)
1674.80 (105)
| Key Financial Ratios of Beta Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 15.29 | 22.82 | 19.57 | 14.82 | 7.26 | |
| Diluted EPS (Rs.) | 15.29 | 22.82 | 19.57 | 14.82 | 7.26 | |
| Cash EPS (Rs.) | 22.66 | 27.73 | 26.02 | 20.51 | 12.74 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 127.83 | 120.67 | 100.12 | 80.57 | 65.96 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 127.83 | 120.67 | 100.12 | 80.57 | 65.96 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 218.14 | 205.56 | 164.22 | 129.86 | 82.65 | |
| PBDIT/Share (Rs.) | 37.26 | 36.67 | 33.54 | 27.09 | 16.56 | |
| PBIT/Share (Rs.) | 29.88 | 31.76 | 27.09 | 21.40 | 11.08 | |
| PBT/Share (Rs.) | 20.65 | 30.67 | 26.22 | 20.97 | 10.28 | |
| Net Profit/Share (Rs.) | 15.29 | 22.82 | 19.57 | 14.82 | 7.26 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.07 | 17.83 | 20.42 | 20.85 | 20.03 | |
| PBIT Margin (%) | 13.69 | 15.44 | 16.49 | 16.47 | 13.40 | |
| PBT Margin (%) | 9.46 | 14.91 | 15.96 | 16.14 | 12.43 | |
| Net Profit Margin (%) | 7.00 | 11.10 | 11.91 | 11.41 | 8.78 | |
| Return on Networth / Equity (%) | 11.95 | 18.90 | 19.54 | 18.39 | 11.00 | |
| Return on Capital Employed (%) | 11.64 | 24.86 | 25.39 | 24.19 | 15.69 | |
| Return on Assets (%) | 4.87 | 12.86 | 14.03 | 12.84 | 8.09 | |
| Total Debt/Equity (X) | 0.96 | 0.03 | 0.04 | 0.07 | 0.06 | |
| Asset Turnover Ratio (%) | 0.90 | 1.30 | 1.29 | 1.27 | 92.14 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.18 | 2.38 | 2.70 | 2.43 | 2.39 | |
| Quick Ratio (X) | 3.70 | 1.92 | 2.27 | 2.10 | 1.97 | |
| Inventory Turnover Ratio (X) | 5.00 | 6.70 | 7.81 | 8.64 | 10.33 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,905.33 | 1,162.52 | 588.67 | 533.23 | 110.99 | |
| EV/Net Operating Revenue (X) | 8.65 | 5.88 | 3.73 | 4.27 | 1.40 | |
| EV/EBITDA (X) | 50.66 | 32.97 | 18.26 | 20.48 | 6.97 | |
| MarketCap/Net Operating Revenue (X) | 8.74 | 6.00 | 3.82 | 4.35 | 1.45 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 14.91 | 10.22 | 6.26 | 7.02 | 1.82 | |
| Price/Net Operating Revenue | 8.74 | 6.00 | 3.82 | 4.35 | 1.45 | |
| Earnings Yield | 0.01 | 0.02 | 0.03 | 0.03 | 0.06 |
